Patents by Inventor Bryan B. Molloy

Bryan B. Molloy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4626549
    Abstract: 3-Aryloxy-3-phenylpropylamines and acid addition salts thereof are useful in blocking uptake of monoamines by brain neurons, and are thus effective in treating disorders of sleep, sexual performance, appetite, muscular function, and pituitary function.
    Type: Grant
    Filed: March 31, 1986
    Date of Patent: December 2, 1986
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Klaus K. Schmiegel
  • Patent number: 4596827
    Abstract: The present invention relates to a new class of alkylsulfonamidophenylalkylamines which are potent antiarrhythmic agents having good oral bioavailability properties.
    Type: Grant
    Filed: November 7, 1985
    Date of Patent: June 24, 1986
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4584404
    Abstract: Selective biogenic amine uptake inhibitors, 3-substituted phenyloxy-3-phenylpropyldimethylamines.
    Type: Grant
    Filed: October 24, 1983
    Date of Patent: April 22, 1986
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Klaus K. Schmiegel
  • Patent number: 4569801
    Abstract: The present invention relates to a new class of alkylsulfonamidophenylalkylamines which are potent antiarrhythmic agents having good oral bioavailability properties.
    Type: Grant
    Filed: October 15, 1984
    Date of Patent: February 11, 1986
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4528177
    Abstract: Radioiodine containing phenylbutylammonium salts are valuable imaging agents, particularly for the heart.
    Type: Grant
    Filed: October 18, 1982
    Date of Patent: July 9, 1985
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4395410
    Abstract: Quaternary ammonium salts of certain phenylpropylamines and phenylbutylamines are useful antiarrhythmic drugs. A method for treating arrhythmia and prolonging the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such quaternary ammonium salts are disclosed.
    Type: Grant
    Filed: June 15, 1981
    Date of Patent: July 26, 1983
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4336269
    Abstract: Certain secondary and tertiary para-nitrophenylalkylamines are potent antiarrhythmic agents which prolong the action potential duration of cardiac tissue. A method of treating re-entrant arrhythmias, and pharmaceutical formulations containing paranitrophenylalkylamines, are provided.
    Type: Grant
    Filed: February 24, 1981
    Date of Patent: June 22, 1982
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4313896
    Abstract: 3-Aryloxy-3-phenylpropylamines and acid addition salts thereof, useful as psychotropic agents, particularly as anti-depressants.
    Type: Grant
    Filed: March 9, 1981
    Date of Patent: February 2, 1982
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Klaus K. Schmiegel
  • Patent number: 4314081
    Abstract: 3-Aryloxy-3-phenylpropylamines and acid additions salts thereof, useful as psychotropic agents, particularly as anti-depressants.
    Type: Grant
    Filed: January 10, 1974
    Date of Patent: February 2, 1982
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Klaus K. Schmiegel
  • Patent number: 4289787
    Abstract: Quaternary ammonium salts of certain phenylbutylamines are useful antiarrhythmic drugs. A method for treating arrhythmia and prolonging the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such quaternary ammonium salts are disclosed.
    Type: Grant
    Filed: December 10, 1979
    Date of Patent: September 15, 1981
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4277501
    Abstract: Certain secondary and tertiary para-nitrophenylalkylamines are potent antiarrhythmic agents which prolong the action potential duration of cardiac tissue. A method of treating re-entrant arrhythmias, and pharmaceutical formulations containing para-nitrophenylalkylamines, are provided.
    Type: Grant
    Filed: December 10, 1979
    Date of Patent: July 7, 1981
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4259354
    Abstract: A method of treating re-entrant arrhythmias comprising administering an effective dose of tetra-alkyl quaternary ammonium salt is provided. Pharmaceutical formulations containing a tetra-alkyl quaternary ammonium salt as the active ingredient are disclosed.
    Type: Grant
    Filed: June 25, 1979
    Date of Patent: March 31, 1981
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Mitchell I. Steinberg
  • Patent number: 4207343
    Abstract: 1-Phenyl-3-(optionally substituted phenoxy)-propylamines, inhibitors of norepinephrine uptake.
    Type: Grant
    Filed: June 22, 1978
    Date of Patent: June 10, 1980
    Assignee: Eli Lilly and Company
    Inventors: Edward R. Lavagnino, Lawrence J. McShane, Bryan B. Molloy
  • Patent number: 4194009
    Abstract: 3-Aryloxy-3-phenylpropylamines and acid additions salts thereof, useful as psychotropic agents, particularly as anti-depressants.
    Type: Grant
    Filed: September 15, 1976
    Date of Patent: March 18, 1980
    Assignee: Eli Lilly and Company
    Inventors: Bryan B. Molloy, Klaus K. Schmiegel
  • Patent number: 4168388
    Abstract: Trifluoromethylphenols are prepared by hydrogenation of the corresponding trifluoromethylbenzylethers.
    Type: Grant
    Filed: March 23, 1978
    Date of Patent: September 18, 1979
    Assignee: Eli Lilly and Company
    Inventors: Edward R. Lavagnino, Bryan B. Molloy, Paul Pranc
  • Patent number: 4132737
    Abstract: 4(5 or 6 or 7)-Trifluoromethyl-1-aminoindanes, useful as inhibitors of N-methyl transferase.
    Type: Grant
    Filed: February 27, 1978
    Date of Patent: January 2, 1979
    Assignee: Eli Lilly and Company
    Inventor: Bryan B. Molloy
  • Patent number: 4098890
    Abstract: Cardiac arrhythmia is treated orally or parenterally with diarylalkylamines and diarylalkenylamines.
    Type: Grant
    Filed: May 27, 1976
    Date of Patent: July 4, 1978
    Assignee: Eli Lilly and Company
    Inventor: Bryan B. Molloy
  • Patent number: 4096173
    Abstract: 4-Chloro and 4,5-, 5,6- and 6,7-dichloro-1-aminoindanes, useful as inhibitors of norephineprine N-methyl transferase.
    Type: Grant
    Filed: March 28, 1977
    Date of Patent: June 20, 1978
    Assignee: Eli Lilly and Company
    Inventor: Bryan B. Molloy
  • Patent number: 4034011
    Abstract: Certain 1,1-diphenyl-4-(substituted-amino)butanes are particularly valuable as antiarrhythmic agents.
    Type: Grant
    Filed: March 12, 1976
    Date of Patent: July 5, 1977
    Assignee: Eli Lilly and Company
    Inventor: Bryan B. Molloy
  • Patent number: 4018897
    Abstract: Novel 1-aryl-1-benzocycloalkyl-4-aminobutanes and 1-aryl-1-benzocycloalkyl-4-amino-1-butenes are useful as antiarrhythmic agents.
    Type: Grant
    Filed: March 15, 1976
    Date of Patent: April 19, 1977
    Assignee: Eli Lilly and Company
    Inventor: Bryan B. Molloy